The challenge of managing headache disorders in a tertiary referral neurology clinic in Rwanda

References

1. ↵
   1. Onwuekwe I,
   2. Ezeala-Adikaibe B

   (2011) Prevalence and distribution of neurological disease in a neurology clinic in enugu, Nigeria. Ann Med Health Sci Res 1, 63–67.
2. ↵
   1. Tegueu CK,
   2. Nguefack S,
   3. Doumbe J,
   4. Fogang YF,
   5. Mbonda PC,
   6. Mbonda E

   (2013) The spectrum of neurological disorders presenting at a neurology clinic in Yaoundé, Cameroon. Pan Afr Med J 14, 148.
3. ↵
   1. World Health Organisation (WHO)

   Headache disorders (WHO, Geneva (CH)) Available from: http://www.who.int/mediacentre/factsheets/fs277/en/. Accessed 30 August 2015.
4. ↵
   1. Headache Classification Committee of the International Headache Society (IHS)

   (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33, 629–808.
5. ↵
   1. Hu XH,
   2. Markson LE,
   3. Lipton RB,
   4. Stewart WF,
   5. Berger ML

   (1999) Burden of migraine in the United States: disability and economic costs. Arch Intern Med 159, 813–818.
6. 1. Woldeamanuel YW,
   2. Andreou AP,
   3. Cowan RP

   (2014) Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies. J Neurol Sci 342, 1–15.
7. ↵
   1. Wahab KW,
   2. Ugheoke AJ

   (2009) Migraine: prevalence and associated disability among Nigerian undergraduates. Can J Neurol Sci 36, 216–221.
8. ↵
   1. Mbewe E,
   2. Zairemthiama P,
   3. Paul R,
   4. Birbeck GL,
   5. Steiner TJ

   (2015) The burden of primary headache disorders in Zambia: national estimates from a population-based door-to-door survey. J Headache Pain 16, 513.
9. ↵
   1. Martelletti P,
   2. Steiner TJ

   1. Haimanot RT

   (2011) Headache in the tropics: Sub-Saharan Africa. in Handbook of headache. Practical management, eds Martelletti P, Steiner TJ (Springer, New York (NY)), 533–540.
10. ↵
    1. Robbins L

    (2014) Medication overuse headache: inaccurate and overdiagnosed. Headache 54, 1656–1657.
11. ↵
    1. Gururaj G,
    2. Kulkarni GB,
    3. Rao GN,
    4. Subbakrishna DK,
    5. Stovner LJ,
    6. Steiner TJ

    (2014) Prevalence and sociodemographic correlates of primary headache disorders: results of a population-based survey from Bangalore, India. Indian J Public Health 58, 241–248.
12. ↵
    1. Tekle Haimanot R,
    2. Seraw B,
    3. Forsgren L,
    4. Ekbom K,
    5. Ekstedt J

    (1995) Migraine, chronic tension-type headache, and cluster headache in an Ethiopian rural community. Cephalalgia 15, 482–488.
13. ↵
    1. Ofovwe GE,
    2. Ofili AN

    (2010) Prevalence and impact of headache and migraine among secondary school students in Nigeria. Headache 50, 1570–1575.
14. 1. Ojini FI,
    2. Okubadejo NU,
    3. Danesi M

    (2009) Prevalence and clinical characteristics of headache in medical students of the University of Lagos, Nigeria. Cephalalgia 29, 472–477.
15. ↵
    1. Onwuekwe I,
    2. Onyeka T,
    3. Aguwa E,
    4. Ezeala-Adikaibe B,
    5. Ekenze O,
    6. Onuora E

    (2014) Headache prevalence and its characterization amongst hospital workers in Enugu, South East Nigeria. Head Face Med 10, 48.
16. ↵
    1. Martin BC,
    2. Dorfman JH,
    3. McMillan JA,
    4. McMillan CA

    (1994) Prevalence of migraine headache and association with sex, age, race, and rural/urban residence: a population-based study of Georgia Medicaid recipients. Clin Ther 16, 855–872.
17. ↵
    1. Stovner Lj,
    2. Hagen K,
    3. Jensen R,
    4. Katsarava Z,
    5. Lipton R,
    6. Scher A,
    7. et al.

    (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193–210.
18. ↵
    1. Jensen R,
    2. Stovner LJ

    (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7, 354–361.
19. ↵
    1. Mbewe E,
    2. Zairemthiama P,
    3. Yeh HH,
    4. Paul R,
    5. Birbeck GL,
    6. Steiner TJ

    (2015) The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 16, 515.
20. ↵
    1. Westergaard ML,
    2. Hansen EH,
    3. Glümer C,
    4. Olesen J,
    5. Jensen RH

    (2014) Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia 34, 409–425.
21. ↵
    1. Rottbeck R,
    2. Nshimiyimana JF,
    3. Tugirimana P,
    4. Düll UE,
    5. Sattler J,
    6. Hategekimana JC,
    7. et al.

    (2013) High prevalence of cysticercosis in people with epilepsy in southern Rwanda. PLoS Negl Trop Dis 7, e2558.
22. ↵
    1. Morris Z,
    2. Whiteley WN,
    3. Longstreth WT Jr.,
    4. Weber F,
    5. Lee YC,
    6. Tsushima Y,
    7. et al.

    (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339, b3016.
23. ↵
    1. Locker TE,
    2. Thompson C,
    3. Rylance J,
    4. Mason SM

    (2006) The utility of clinical features in patients presenting with nontraumatic headache: an investigation of adult patients attending an emergency department. Headache 46, 954–961.
24. ↵
    1. Locker T,
    2. Mason S,
    3. Rigby A

    (2004) Headache management – Are we doing enough? An observational study of patients presenting with headache to the emergency department. Emerg Med J 21, 327–332.
25. 1. Detsky ME,
    2. McDonald DR,
    3. Baerlocher MO,
    4. Tomlinson GA,
    5. McCrory DC,
    6. Booth CM

    (2006) Does this patient with headache have a migraine or need neuroimaging? JAMA 296, 1274–1283.
26. ↵
    1. Duncan CW

    (2002) Neuroimaging and other investigation in patients presenting with headache. Ann Indian Acad Neurol 15, S23–S32.
27. ↵
    1. Moras K,
    2. Nischal H

    (2014) Impact of amitriptyline on migraine disability assessment score. J Clin Diagn Res 8, KC01–KC02.
28. 1. Yancey JR,
    2. Sheridan R,
    3. Koren KG

    (2014) Chronic daily headache: diagnosis and management. Am Fam Physician 89, 642–648.
29. ↵
    1. Bendtsen L,
    2. Jensen R

    (2011) Treating tension-type headache - an expert opinion. Expert Opin Pharmacother 12, 1099–1109.
30. ↵
    1. Linde M,
    2. Steiner TJ,
    3. Chisholm D

    (2015) Cost-effectiveness analysis of interventions for migraine in for low-and middle-income countries. J Headache Pain 16, 15.
31. ↵
    1. Smith R

    (1989) Management of chronic headache. Can Fam Physician 35, 1835–1839.
32. ↵
    1. Lyngberg AC,
    2. Rasmussen BK,
    3. Jorgensen T,
    4. Jensen R

    (2005) Prognosis of migraine and tension-type headache. Neurology 65, 580–585.
33. ↵
    1. Singh NN,
    2. Sahota P

    (2013) Sleep-related headache and its management. Curr Treat Options Neurol 15, 704–722.
34. ↵
    1. Giamberardino MA,
    2. Mitsikostas DD,
    3. Martelletti P

    (2015) Update on Medication-Overuse Headache and Its Treatment. Curr Treat Options Neurol 17, 368.
35. ↵
    1. Brett J,
    2. Murnion B

    (2015) Management of benzodiazepine misuse and dependence. Aust Prescr 38, 152–155.
36. ↵
    1. Schramm SH,
    2. Moebus S,
    3. Lehmann N,
    4. Galli U,
    5. Obermann M,
    6. Bock E,
    7. et al.

    (2014) The association between stress and headache: A longitudinal population-based study. Cephalalgia 35, 853–863.
37. ↵
    1. Bolton P,
    2. Neugebauer R,
    3. Ndogoni L

    (2002) Prevalence of depression in Rwandan based on symptom and functional criteria. J Ner Ment Dis 190, 631–637.
38. 1. Rieder H,
    2. Elbert T

    (2013) Rwanda - lasting imprints of a genocide: trauma, mental health and psychosocial conditions in survivors, former prisoners and their children. Confl Health 7, 6.
39. ↵
    1. Roth M,
    2. Neuner F,
    3. Elbert T

    (2014) Transgenerational consequences of PTSD: risk factors for the mental health of children whose mothers have been exposed to the Rwandan genocide. Int J Ment Health Syst 8, 12.